Breath Volatile Organic Compounds are Novel Biomarkers to Differentiate Glycogen Storage Disease from Nonalcoholic Fatty Liver Disease

被引：0
|
作者：
Kabbany, Mohammad Nasser [1 ]
Mehta, Neal A. [2 ]
Selvakumar, Praveen Kumar Conjeevaram [1 ]
Grove, David [3 ]
Lopez, Rocio [4 ]
Raheem, Sulieman Abdal [4 ]
Dweik, Raed A. [5 ]
Tsilianidis, Laurie [6 ]
Alkhouri, Naim [1 ,4 ]
机构：
[1] Cleveland Clin Fdn, Dept Pediat Gastroenterol & Hepatol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Learner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA
[4] Cleveland Clin Fdn, Inst Digest Dis, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Cleveland Clin Fdn, Dept Pulm Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[6] Cleveland Clin Fdn, Dept Pediat Endocrinol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
807
引用
收藏
页码：432A / 432A
页数：1
相关论文
共 50 条
  • [21] ARE BIOMARKERS FOR CARDIOVASCULAR DISEASE INCREASED IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)?
    Elsheikh, Elzafir
    Tran, Henry A.
    Paik, James
    Felix, Sean C.
    Jeffers, Thomas
    Younoszai, Zahra
    Locklear, Cameron T.
    Allawi, Hussain
    Fang, Yun
    Arsalla, Aimal
    Noor, Bashir
    Kalachi, Kourosh
    Racila, Andrei
    Lam, Brian P.
    Goodman, Zachary
    Gerber, Lynn
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2018, 154 (06) : S950 - S950
  • [22] Identification of biomarkers that measure disease activity in patients with nonalcoholic fatty liver disease
    Malik, R.
    Lai, M.
    Bhaskar, K.
    Nasser, I.
    Curry, M.
    Schuppan, D.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S355 - S355
  • [23] The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
    Sharma, Mithun
    Mitnala, Shasikala
    Vishnubhotla, Ravi K.
    Mukherjee, Rathin
    Reddy, Duvvur N.
    Rao, Padaki N.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 147 - 158
  • [24] Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
    Raman, Maitreyi
    Ahmed, Iftikhar
    Gillevet, Patrick M.
    Probert, Chris S.
    Ratcliffe, Norman M.
    Smith, Steve
    Greenwood, Rosemary
    Sikaroodi, Masoumeh
    Lam, Victor
    Crotty, Pam
    Bailey, Jennifer
    Myers, Robert P.
    Rioux, Kevin P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 868 - +
  • [25] Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
    Hua Jiang
    Yang Hu
    Zhibo Zhang
    Xujia Chen
    Jianpeng Gao
    Lipids in Health and Disease, 22
  • [26] Serum Biomarkers for Nonalcoholic Fatty Liver Disease: Are We There Yet?
    Liu, Ken
    Xu, Weiqi
    Wong, Vincent Wai-Sun
    HEPATOLOGY, 2017, 65 (01) : 8 - 11
  • [27] Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
    Carlos J Pirola
    Silvia Sookoian
    World Journal of Gastroenterology, 2018, 24 (15) : 1601 - 1615
  • [28] Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
    Pirola, Carlos J.
    Sookoian, Silvia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (15) : 1601 - 1615
  • [29] Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease
    Amacher, David E.
    BIOMARKERS, 2014, 19 (07) : 541 - 552
  • [30] NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?
    Singh, Shivaram P.
    Barik, Rakesh K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (01) : 88 - 98
12345